Abstract
PUVA (psoralen and near ultraviolet light) is a DNA-damaging, clinically effective treatment. If we have patience, studies of PUVA therapy should give us a rare opportunity to learn much about not only the diseases it treats, but also about diseases it may cause. PUVA is a gamble, a calculated risk.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Al-Saleem, R., Ali, Z.S., and Qassah, M., 1980, Skin cancers in xeroderma pigmentosum: response to indomethacin and steroids. Lancet, ii: 264.
Arlett, C.F., Heddle, J.A., Broughton, B.C., and Rogers, A.M., 1980, Cell killing and mutagenesis by 8-methoxypsoralen in mammalian (rodent) cells. Clin. Exp. Dermatol., 5: 147.
Ashwood-Smith, M.J., Grant, E.L., Heddle, J.A., and Friedman, G.B., 1977, Chromosome damage in Chinese hamster cells sensitized to near-ultraviolet light by psoralen and angelicin, Mutation Res., 43: 377.
Baltimore, D., 1974, Is terminal deoxynucleotidyl transferase a somatic mutagen for lymphocytes?, Nature, 248: 409.
Bridges, B.A., 1978, Possible long-term hazards of photochemotherapy with psoralens and near-ultraviolet light, Clin. Exp. Dermatol., 3: 349.
Bridges, B.A., 1979, An estimate of genetic risk from 8-methoxypsoralen photochemotherapy, Hum. Genet., 49: 91.
Bridges, B.A. and Strauss, G.H., 1980, Possible hazards of photochemotherapy for psoriasis, Nature, 218: 523.
Bridges, B.A., Greaves, M., Polani, P.E., and Wald, N., in press, Do treatments available for psoriasis patients carry a genetic or carcinogenic risk? A report from an expert group of the International Commission for Protection against Environmental Mutagens and Carcinogens, Mutation Res. and Biol. Zentr.
Bridges, B.A., Strauss, G.H., Hall-Smith, P., and Price, M., 1981, Induction of somatic mutations and impairment of immune capacity by PUVA treatment and their relation to skin cancer in man, in: “Psoralens in Cosmetics and Dermatology”, Pergamon Press, Paris.
Catalona, W.J., Taylor, P.T. and Chretieu, P.B., 1972, Quantitative dinitrochlorobenzene contact sensitization in a normal population, Clin. Exp. Immunol., 12: 325.
Cormane, R.H., Hamerlinck, F. and Siddiqui, A.H., 1979, Immunologic implications of PUVA therapy in psoriasis vulgaris, Arch. Dermatol. Res., 265: 275.
Evans, D.L., and Morrow, R.J., 1979, 8-methoxypsoralen induced alterations of mammalian cells, J. Invest. Dermatol., 72: 35.
Griffin, A.C., 1959, Methoxsalen in ultraviolet carcinogenesis in the mouse. J. Invest. Dermatol. 31: 367.
Igali, S., Bridges, B.A., Ashwood-Smith, M.J., and Scott, B.R., 1970, Mutagenesis in Escherichia coli IV, Photosensitization to near-ultraviolet light by 8-methoxypsoralen, Mutation Res., 9: 21.
Kerkis, J.J., and Skorova, S.V., 1973, Humoral factors of “spontaneous” mutagenesis in mammals and man. Mutation Res., 18: 179.
Kinlin, L., et al., 1979, Collaborative United Kingdom/Australian study of cancer patients treated with immunosuppressive drugs, Brit. Med. J., 2: 1461.
Kraemer, R.H. and Weinstein, G.D., 1977, Decreased thymidine incorporation in circulating leukocytes after treatment of psoriasis with psoralen and long-wave ultraviolet light, J. Invest. Dermatol., 69: 211.
Malling, H.V., 1976, Mutagenesis testing: mammalian systems. Mutation Res., 41: 171.
Melski, J.W., Tanenbaum, L., Parrish, J.A., et al., 1977, Oral methoxsalen photochemotherapy for the treatment of psoriasis: a co-operative clinical trial, J. Invest. Dermatol., 68: 328.
Morhenn, V.B., Benike, B.S., and Engleman, E.G., 1980, Inhibition of cell mediated immune response by 8-methoxypsoralen and long-wave ultraviolet light: a possible explanation for the clinical effects of photo-activated psoralens, J. Invest. Dermatol., 75: 249.
Morison, W.L., Woehler, M.E., and Parrish, J.A., 1979, PUVA and systemic immunosuppression in guinea pigs. J. Invest. Dermatol., 72: 273.
Morison, W.L., Parrish, J.A., McAuliffe, D.J. and Bloch, K.J., 1981, Sensitivity of mononuclear cells to PUVA: effect on subsequent stimulation with mitogens and on exclusion of trypan blue dye, Clin. Exp. Dermatol., 6: 273.
Parrish, J.A., Fitzpartick, T.B., Tanenbaum, L., and Pathak, M.A., 1974, Photochemotherapy for psoriasis with oral methoxsalen and longwave ultraviolet light, New Engl. J. Med., 291: 1207.
Parrish, J.A., LeVine, M.J., and Fitzpatrick, T.B., 1980, Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides, Int. J. Dermatol., 19: 379.
Reed, W.D., 1976, Treatment of psoriasis with oral psoralens and longwave ultraviolet light, Acta Dermato-vener., 56: 315.
Roberts, L.K., Schmitt, M., and Daynes, R.A., 1979, Tumour susceptibility generated in mice treated with subcarcinogenic doses of 9-methoxypsoralen and longwave ultraviolet light, J. Invest. Dermatol., 72: 306.
Stern, R.S., Thibodeau, L.A., Kleinerman, R.A., Parrish, J.A., Fitzpatrick, et al., 1979, Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis, New. Engl. J. Med., 300–309.
Strauss, G.H., in press, PUVA-Gambling with a system? Int. J. Dermatol.
Strauss, G.H., and Albertini, R.J., 1979, Enumeration of 6-thioguanine peripheral blood lymphocytes as a potential test for somatic cell mutations arising in vivo, Mutation Res., 61: 353.
Strauss, G.H., Albertini, R.J., Krusinki, P.A., and Baughman, R.D., 1979, 6-thioguanine-resistant peripheral blood lymphocytes in humans following psoralen longwave UV light therapy, J. Invest. Dermatol., 73: 211.
Strauss, G.H., Bridges, B.A., Greaves, M., Hall-Smith, P., Price, M., and Vella-Briffa, D. 1980, Inhibition of delayed hypersensitivity reaction in skin (DNCB test) by 8-methoxypsoralen photochemotherapy: possible basis for pseudo-promoting action in skin carcinogenesis? Lancet, 2: 556.
Svejgaard, A., Nielsen, L., Svejgaard, E., Kissmeyer-Nielsen, F., Hjortshcj, A., and Zachariae, H., 1974, HL-A in psoriasis vulgaris and in pustular psoriasis-population and family studies, Brit. J. Dermatol., 91: 145.
Toews, G., Borgstresser, P.R., and Streilein, J.W., 1980, Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB, J. Immunol., 124: 445.
Updike, J., 1979, From the journal of a leper, in: “Problems and Other Stories”, Knopf, New York.
Vella-Briffa, D., and Warin, A.P., 1979, Photochemotherapy in psoriasis: A review, J. R. Soc. Med., 72: 440.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1983 Springer Science+Business Media New York
About this chapter
Cite this chapter
Strauss, G.H.S. (1983). PUVA Therapy: Immunologic and Genotoxic Approaches to Risk Evaluation. In: Castellani, A. (eds) The Use of Human Cells for the Evaluation of Risk from Physical and Chemical Agents. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-1117-2_17
Download citation
DOI: https://doi.org/10.1007/978-1-4757-1117-2_17
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-1119-6
Online ISBN: 978-1-4757-1117-2
eBook Packages: Springer Book Archive